Deep venous thrombosis after central catheter insertion in cancer patients;Thromboses veineuses sur cathéters centraux en cancérologie

Presse Medicale

Volumn 30, Issue 6, 2001, Pages 298-301

  Gratadou, D ^a   Elias, A ^a   Elias, M ^a   Boccalon, H ^a  

^a CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANTICOAGULANT THERAPY; ARTICLE; CANCER PATIENT; CATHETERIZATION; DEEP VEIN THROMBOSIS; DIAGNOSTIC IMAGING; DRUG EFFICACY; HUMAN; PREVALENCE; PROPHYLAXIS; SUPERIOR CAVA VEIN SYNDROME;

ANTICOAGULANTS; ANTINEOPLASTIC AGENTS; CATHETERIZATION, CENTRAL VENOUS; FIBRINOLYTIC AGENTS; HUMANS; NEOPLASMS; VENOUS THROMBOSIS;

EID: 0035901061     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Are clinical signs accurate indicators of the cause of central venous catheter occlusion?
2. Fibrin sleeve formation after long-term brachial catheterization with an implantable port device. A prospective venographic study
3. Thrombin activity associated with indwelling central venous catheters
4. Thrombosis and infection caused by thoracic venous catheters : Pathogenesis and imaging findings
5. Groshong catheter-associated subclavian venous thrombosis
6. The timing and sequence of multiple device-related complications in patients with long-term indwelling groshong catheters
7. Upper extremity venous thrombosis diagnosed by duplex scanning
8. Thrombose des cathéters veineux centraux : Prévention et traitement
9. Complications with fully implantable venous access systems in oncologic patients
10. Complications of indwelling venous access devices in cancer patients
11. Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: A randomized trial in 100 patients with solid tumors
12. Implantable devices for central venous access in cancer patients. Our experience in 217 cases
13. Fully implantable catheter systems. Long-term results - Complications
14. Double-blind randomised trial of very low-dose Warfarin for prevention of thromboembolism in stage IV breast cancer
15. Hickman catheter-induced thoracic vein thrombosis. Frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantation
16. Upper-extremity deep venous thrombosis : Analysis of 52 cases
17. Thrombosis : The major hickman catheter complication in patients with solid tumor
18. Continuous infusion of low-dose urokinase in the treatment of central venous catheter thrombosis in infants and children
19. A cross-sectional study of catheter-related thrombosis in children receiving total parenteral nutrition at home
20. The relationship between the thrombotic and infections complications of central venous catheters
21. Central venous catheter-related thrombosis in clinically asymptomatic oncologic patients : A phlebographic study
22. Evaluation of Doppler examination for diagnosis of catheter- related deep vein thrombosis
23. Very low doses of Warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial
24. The risk factors in central venous catheters-related thrombosis
25. Prevalence of deep venous thrombosis among patients in medical intensive care
26. Deep vein thrombosis of the arm associated with malignancy
27. Antithrombin III deficiency as a risk factor for catheter-related central vein thrombosis in cancer patients
28. Upper extremity deep vein thrombosis. Risk factors, diagnosis and complications
29. Pulmonary embolism in deep venous thrombosis of the upper extremity: More often in catheter-related thrombosis
30. Les thromboses veineuses sur cathéter central en cancérologie
31. Venographic surveillance of tunneled venous access devices in adult oncology patients
32. Upper-extremity deep venous thrombosis and pulmonary embolism. A prospective study
33. La thrombose veineuse profonde des membres supérieurs. Revue de la littérature à propos d'un cas de syndrome de Paget-Schrötter
34. Les thromboses veineuses profondes des membres supérieurs
35. Thromboses veineuses des membres supérieurs : Première partie
36. Infectious morbidity associated with long-term use of venous access devices in patients with cancer
37. Cancer and venous thromboembolism
38. Central venous catheter related thrombosis
39. Upper extremity deep venous thrombosis in cancer patients with venous access devices. Prophylaxis with a low molecular weight heparin (Fragmin)
40. Long-term outcomes of radiologically placed arm ports
41. Phlegmatia cerulea dolens of the upper extremity
42. Complications associated with the use of central venous access devices
43. Acute superior vena cava syndrome after central venous catheter placement
44. Exploration des veines par les ultrasons
45. Utility of duplex ultrasound in the diagnosis of asymptomatic catheter-induced subclavian vein thrombosis
46. Duplex scans before subclavian vein catheterization predict unsuccessful catheter placement
47. The diagnosis value of colour doppler ultrasound in central venous catheter related thrombosis
48. Color Doppler sonographic imaging in the assessment of upper-extremity deep venous thrombosis
49. Upper extremity impedance plethysmography in patients with venous access devices
50. Deep venous thrombosis extremities: Role of M.R. imaging in the diagnosis
51. Prophylaxis against central vein thrombosis with low dose Warfarin
52. Benefit of heparin in central venous and pulmonary artery catheters. A meta-analysis of randomized controlled trials
53. Obstructed central venous catheters. Restoring function with 12-hour infusion of low-dose Urokinase
54. Sténoses veineuses centrales en hémodialyse: Étude angiographique comparative des accès sous-claviers et jugulaires internes
55. Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters : A double-blinded, randomized trial
56. Fibrinolyse des thromboses veineuses profondes sur dispositifs de perfusion implantables. A propos d'une série consécutive de 57 thromboses et 32 fibrinolyses
57. Treatment of superior vena cava thrombosis with recombinant tissue type plasminogen activator